1. Home
  2. ADCT vs CMCM Comparison

ADCT vs CMCM Comparison

Compare ADCT & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • CMCM
  • Stock Information
  • Founded
  • ADCT 2011
  • CMCM 2009
  • Country
  • ADCT Switzerland
  • CMCM China
  • Employees
  • ADCT N/A
  • CMCM N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • CMCM Computer Software: Prepackaged Software
  • Sector
  • ADCT Health Care
  • CMCM Technology
  • Exchange
  • ADCT Nasdaq
  • CMCM Nasdaq
  • Market Cap
  • ADCT 143.1M
  • CMCM 148.5M
  • IPO Year
  • ADCT 2020
  • CMCM 2014
  • Fundamental
  • Price
  • ADCT $1.49
  • CMCM $4.38
  • Analyst Decision
  • ADCT Strong Buy
  • CMCM
  • Analyst Count
  • ADCT 5
  • CMCM 0
  • Target Price
  • ADCT $8.50
  • CMCM N/A
  • AVG Volume (30 Days)
  • ADCT 344.2K
  • CMCM 36.9K
  • Earning Date
  • ADCT 03-27-2025
  • CMCM 03-26-2025
  • Dividend Yield
  • ADCT N/A
  • CMCM N/A
  • EPS Growth
  • ADCT N/A
  • CMCM N/A
  • EPS
  • ADCT N/A
  • CMCM N/A
  • Revenue
  • ADCT $70,837,000.00
  • CMCM $110,544,725.00
  • Revenue This Year
  • ADCT $6.81
  • CMCM $37.71
  • Revenue Next Year
  • ADCT $11.24
  • CMCM $39.26
  • P/E Ratio
  • ADCT N/A
  • CMCM N/A
  • Revenue Growth
  • ADCT 1.84
  • CMCM 20.52
  • 52 Week Low
  • ADCT $1.39
  • CMCM $2.70
  • 52 Week High
  • ADCT $5.38
  • CMCM $6.78
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 39.46
  • CMCM 33.91
  • Support Level
  • ADCT $1.41
  • CMCM $4.90
  • Resistance Level
  • ADCT $1.68
  • CMCM $5.07
  • Average True Range (ATR)
  • ADCT 0.12
  • CMCM 0.27
  • MACD
  • ADCT -0.03
  • CMCM -0.05
  • Stochastic Oscillator
  • ADCT 16.00
  • CMCM 8.41

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: